Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Gide, TN; Quek, C; Menzies, AM; Tasker, AT; Shang, P; Holst, J; Madore, J; Lim, SY; Velickovic, R; Wongchenko, M; Yan, YB; Lo, S; Carlino, MS; Guminski, A; Saw, RPM; Pang, A; McGuire, HM; Palendira, U; Thompson, JF; Rizos, H; da Silva, IP; Batten, M;

Wilmott, JS (reprint author), Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2065, Australia.; Wilmott, JS (reprint author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.

CANCER CELL, 2019; 35 (2): 238

Abstract

Cancer immunotherapies provide survival benefits in responding patients, but many patients fail to respond. Identifying the biology of treatment respo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索